editas medicine - Robuta Search

https://www.home.saxo/en-gb/markets/stocks/edit-xnas Editas Medicine Inc. stock | Saxo Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of... editas medicine inc stock saxo https://www.weforum.org/organizations/editas-medicine/ Editas Medicine | World Economic Forum The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic... editas medicine world economic forum https://www.fiercebiotech.com/keyword/editas-medicine Editas Medicine | Fierce Biotech editas medicine fierce biotech https://finviz.com/news/333381/editas-medicine-announces-fourth-quarter-and-full-year-2025-results-and-business-updates Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates Stock screener for investors and traders, financial visualizations. full year 2025 results editas medicine fourth quarter https://finviz.com/news/318549/editas-medicine-to-participate-in-upcoming-investor-conferences Editas Medicine to Participate in Upcoming Investor Conferences Stock screener for investors and traders, financial visualizations. editas medicine to participate upcoming investor conferences https://www.nasdaq.com/market-activity/stocks/edit/sec-filings Editas Medicine, Inc. Common Stock (EDIT) SEC Filings | Nasdaq Find the latest SEC Filings data for Editas Medicine, Inc. Common Stock (EDIT) including 10-K and 10-Q forms at Nasdaq.com. editas medicine common stock sec filings inc nasdaq https://www.macrotrends.net/stocks/charts/EDIT/editas-medicine/price-sales Editas Medicine Price to Sales Ratio 2015-2026 | EDIT | MacroTrends price to sales ratio editas medicine 2015 2026 macrotrends https://finviz.com/quote?t=EDIT&ty=c&ta=1&p=d EDIT - Editas Medicine Inc Stock Price and Quote EDIT - Editas Medicine Inc - Stock screener for investors and traders, financial visualizations. editas medicine stock price inc quote https://finviz.com/quote?t=EDIT&ta=1&p=d&ty=tr EDIT - Editas Medicine Inc Website Traffic and Mobile Apps Usage EDIT - Editas Medicine Inc - Stock screener for investors and traders, financial visualizations. editas medicine website traffic mobile apps inc usage https://www.ig.com/jp/shares/markets-shares/editas-medicine-inc Editas Medicine Inc Editas Medicine, Inc. is a genome-editing company developing potentially transformative genomic medicines to treat a broad range of serious... [JP] editas medicine inc https://www.lawinsider.com/contracts/10IK3kwDmKs COLLABORATION AND LICENSE AGREEMENT by Editas Medicine, Inc. | Law Insider COLLABORATION AND LICENSE AGREEMENT filed by Editas Medicine, Inc. on November 8th, 2018 license agreement editas medicine collaboration inc law https://finviz.com/quote?t=EDIT&ta=1&p=d&ty=ea EDIT - Editas Medicine Inc Earnings EDIT - Editas Medicine Inc - Stock screener for investors and traders, financial visualizations. editas medicine inc earnings https://www.biospace.com/b-gates-b-backed-editas-medicine-sets-terms-for-122-million-crispr-ipo Gates-Backed Editas Medicine Sets Terms for $122 Million CRISPR IPO - BioSpace editas medicine https://www.globenewswire.com/news-release/2025/05/14/3080998/0/en/Editas-Medicine-Reports-New-In-Vivo-Data-Highlighting-the-Potential-of-Editas-Gene-Upregulation-Strategy-in-HSCs-at-the-American-Society-of-Gene-and-Cell-Therapy-Annual-Meeting.html Editas Medicine Reports New In Vivo Data Highlighting the Data demonstrate therapeutically relevant editing levels using a clinically validated strategy, supporting its development as a novel, in vivo approach to... editas medicine reports new vivo data highlighting https://www.nasdaq.com/market-activity/stocks/edit/earnings Editas Medicine, Inc. Common Stock (EDIT) Earnings Report Date | Nasdaq Find annual and quearterly earnings data for Editas Medicine, Inc. Common Stock (EDIT) including earnings per share, earnings forecasts at Nasdaq.com. editas medicine common stock earnings report inc date https://www.fool.com/investing/2025/08/15/why-editas-medicine-stock-was-skyrocketing-this-we/ Why Editas Medicine Stock Was Skyrocketing This Week | The Motley Fool Aug 15, 2025 - The company's CEO made quite the encouraging statement regarding its immediate future. editas medicine this week the motley stock https://www.fool.com/investing/2018/05/05/editas-medicine-starts-a-transformative-ye.aspx Editas Medicine Starts a "Transformative" Year on a High Note | The Motley Fool May 5, 2018 - The CRISPR gene-editing company delivered a strong first quarter. Here's what investors need to know. editas medicine year on https://www.fool.com/earnings/call-transcripts/2021/11/08/editas-medicine-inc-edit-q3-2021-earnings-call-tra/ Editas Medicine, Inc (EDIT) Q3 2021 Earnings Call Transcript | The Motley Fool Nov 8, 2021 - EDIT earnings call for the period ending September 30, 2021. earnings call transcript editas medicine https://www.finanznachrichten.de/nachrichten-2025-05/65382013-editas-medicine-inc-editas-medicine-announces-u-s-court-of-appeals-for-the-federal-circuit-remands-crispr-patent-interference-to-patent-trial-and-399.htm Editas Medicine, Inc.: Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit... CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court... u s court of appeals https://www.biospace.com/editas-medicine-announces-fda-clearance-of-investigational-new-drug-ind-application-for-edit-301-for-the-treatment-of-transfusion-dependent-beta-thalassemia Editas Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for EDIT-301... Dec 20, 2021 - Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the IND... https://finviz.com/news/340474/editas-medicine-announces-us-patent-and-trademark-office-reaffirms-its-prior-decision-in-favor-of-the-broad-institute-in-crisprcas9-interference Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of... Stock screener for investors and traders, financial visualizations.